Intestinal function and transit associate with gut microbiota dysbiosis in cystic fibrosis
•Faecal microbiota significantly differs between pwCF and healthy controls.•Known SCFA producers contributed to microbiota dissimilarity between groups.•Pulmonary antibiotic treatment heavily impacted gut microbiota.•Intestinal physiology and transit impacted satellite microbiota composition. Most p...
Saved in:
Published in | Journal of cystic fibrosis Vol. 21; no. 3; pp. 506 - 513 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
01.05.2022
|
Subjects | |
Online Access | Get full text |
ISSN | 1569-1993 1873-5010 1873-5010 |
DOI | 10.1016/j.jcf.2021.11.014 |
Cover
Loading…
Abstract | •Faecal microbiota significantly differs between pwCF and healthy controls.•Known SCFA producers contributed to microbiota dissimilarity between groups.•Pulmonary antibiotic treatment heavily impacted gut microbiota.•Intestinal physiology and transit impacted satellite microbiota composition.
Most people with cystic fibrosis (pwCF) suffer from gastrointestinal symptoms and are at risk of gut complications. Gut microbiota dysbiosis is apparent within the CF population across all age groups, with evidence linking dysbiosis to intestinal inflammation and other markers of health. This pilot study aimed to investigate the potential relationships between the gut microbiota and gastrointestinal physiology, transit, and health.
Faecal samples from 10 pwCF and matched controls were subject to 16S rRNA sequencing. Results were combined with clinical metadata and MRI metrics of gut function to investigate relationships.
pwCF had significantly reduced microbiota diversity compared to controls. Microbiota compositions were significantly different, suggesting remodelling of core and rarer satellite taxa in CF. Dissimilarity between groups was driven by a variety of taxa, including Escherichia coli, Bacteroides spp., Clostridium spp., and Faecalibacterium prausnitzii. The core taxa were explained primarily by CF disease, whilst the satellite taxa were associated with pulmonary antibiotic usage, CF disease, and gut function metrics. Species-specific ordination biplots revealed relationships between taxa and the clinical or MRI-based variables observed.
Alterations in gut function and transit resultant of CF disease are associated with the gut microbiota composition, notably the satellite taxa. Delayed transit in the small intestine might allow for the expansion of satellite taxa resulting in potential downstream consequences for core community function in the colon. |
---|---|
AbstractList | Most people with cystic fibrosis (pwCF) suffer from gastrointestinal symptoms and are at risk of gut complications. Gut microbiota dysbiosis is apparent within the CF population across all age groups, with evidence linking dysbiosis to intestinal inflammation and other markers of health. This pilot study aimed to investigate the potential relationships between the gut microbiota and gastrointestinal physiology, transit, and health.BACKGROUNDMost people with cystic fibrosis (pwCF) suffer from gastrointestinal symptoms and are at risk of gut complications. Gut microbiota dysbiosis is apparent within the CF population across all age groups, with evidence linking dysbiosis to intestinal inflammation and other markers of health. This pilot study aimed to investigate the potential relationships between the gut microbiota and gastrointestinal physiology, transit, and health.Faecal samples from 10 pwCF and matched controls were subject to 16S rRNA sequencing. Results were combined with clinical metadata and MRI metrics of gut function to investigate relationships.STUDY DESIGNFaecal samples from 10 pwCF and matched controls were subject to 16S rRNA sequencing. Results were combined with clinical metadata and MRI metrics of gut function to investigate relationships.pwCF had significantly reduced microbiota diversity compared to controls. Microbiota compositions were significantly different, suggesting remodelling of core and rarer satellite taxa in CF. Dissimilarity between groups was driven by a variety of taxa, including Escherichia coli, Bacteroides spp., Clostridium spp., and Faecalibacterium prausnitzii. The core taxa were explained primarily by CF disease, whilst the satellite taxa were associated with pulmonary antibiotic usage, CF disease, and gut function metrics. Species-specific ordination biplots revealed relationships between taxa and the clinical or MRI-based variables observed.RESULTSpwCF had significantly reduced microbiota diversity compared to controls. Microbiota compositions were significantly different, suggesting remodelling of core and rarer satellite taxa in CF. Dissimilarity between groups was driven by a variety of taxa, including Escherichia coli, Bacteroides spp., Clostridium spp., and Faecalibacterium prausnitzii. The core taxa were explained primarily by CF disease, whilst the satellite taxa were associated with pulmonary antibiotic usage, CF disease, and gut function metrics. Species-specific ordination biplots revealed relationships between taxa and the clinical or MRI-based variables observed.Alterations in gut function and transit resultant of CF disease are associated with the gut microbiota composition, notably the satellite taxa. Delayed transit in the small intestine might allow for the expansion of satellite taxa resulting in potential downstream consequences for core community function in the colon.CONCLUSIONSAlterations in gut function and transit resultant of CF disease are associated with the gut microbiota composition, notably the satellite taxa. Delayed transit in the small intestine might allow for the expansion of satellite taxa resulting in potential downstream consequences for core community function in the colon. Most people with cystic fibrosis (pwCF) suffer from gastrointestinal symptoms and are at risk of gut complications. Gut microbiota dysbiosis is apparent within the CF population across all age groups, with evidence linking dysbiosis to intestinal inflammation and other markers of health. This pilot study aimed to investigate the potential relationships between the gut microbiota and gastrointestinal physiology, transit, and health. Faecal samples from 10 pwCF and matched controls were subject to 16S rRNA sequencing. Results were combined with clinical metadata and MRI metrics of gut function to investigate relationships. pwCF had significantly reduced microbiota diversity compared to controls. Microbiota compositions were significantly different, suggesting remodelling of core and rarer satellite taxa in CF. Dissimilarity between groups was driven by a variety of taxa, including Escherichia coli, Bacteroides spp., Clostridium spp., and Faecalibacterium prausnitzii. The core taxa were explained primarily by CF disease, whilst the satellite taxa were associated with pulmonary antibiotic usage, CF disease, and gut function metrics. Species-specific ordination biplots revealed relationships between taxa and the clinical or MRI-based variables observed. Alterations in gut function and transit resultant of CF disease are associated with the gut microbiota composition, notably the satellite taxa. Delayed transit in the small intestine might allow for the expansion of satellite taxa resulting in potential downstream consequences for core community function in the colon. •Faecal microbiota significantly differs between pwCF and healthy controls.•Known SCFA producers contributed to microbiota dissimilarity between groups.•Pulmonary antibiotic treatment heavily impacted gut microbiota.•Intestinal physiology and transit impacted satellite microbiota composition. Most people with cystic fibrosis (pwCF) suffer from gastrointestinal symptoms and are at risk of gut complications. Gut microbiota dysbiosis is apparent within the CF population across all age groups, with evidence linking dysbiosis to intestinal inflammation and other markers of health. This pilot study aimed to investigate the potential relationships between the gut microbiota and gastrointestinal physiology, transit, and health. Faecal samples from 10 pwCF and matched controls were subject to 16S rRNA sequencing. Results were combined with clinical metadata and MRI metrics of gut function to investigate relationships. pwCF had significantly reduced microbiota diversity compared to controls. Microbiota compositions were significantly different, suggesting remodelling of core and rarer satellite taxa in CF. Dissimilarity between groups was driven by a variety of taxa, including Escherichia coli, Bacteroides spp., Clostridium spp., and Faecalibacterium prausnitzii. The core taxa were explained primarily by CF disease, whilst the satellite taxa were associated with pulmonary antibiotic usage, CF disease, and gut function metrics. Species-specific ordination biplots revealed relationships between taxa and the clinical or MRI-based variables observed. Alterations in gut function and transit resultant of CF disease are associated with the gut microbiota composition, notably the satellite taxa. Delayed transit in the small intestine might allow for the expansion of satellite taxa resulting in potential downstream consequences for core community function in the colon. Highlights•Faecal microbiota significantly differs between pwCF and healthy controls. •Known SCFA producers contributed to microbiota dissimilarity between groups. •Pulmonary antibiotic treatment heavily impacted gut microbiota. •Intestinal physiology and transit impacted satellite microbiota composition. |
Author | Gavillet, Helen Smyth, Alan R Major, Giles Mitchell-Whyte, Mandisa van der Gast, Christopher Hanson, Liam Ng, Christabella Rivett, Damian Marsh, Ryan |
Author_xml | – sequence: 1 givenname: Ryan surname: Marsh fullname: Marsh, Ryan organization: Department of Life Sciences, Manchester Metropolitan University, Manchester, United Kingdom – sequence: 2 givenname: Helen surname: Gavillet fullname: Gavillet, Helen organization: Department of Life Sciences, Manchester Metropolitan University, Manchester, United Kingdom – sequence: 3 givenname: Liam surname: Hanson fullname: Hanson, Liam organization: Department of Life Sciences, Manchester Metropolitan University, Manchester, United Kingdom – sequence: 4 givenname: Christabella surname: Ng fullname: Ng, Christabella organization: School of Medicine, University of Nottingham, Nottingham, United Kingdom – sequence: 5 givenname: Mandisa surname: Mitchell-Whyte fullname: Mitchell-Whyte, Mandisa organization: Wolfson CF Unit, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom – sequence: 6 givenname: Giles surname: Major fullname: Major, Giles organization: School of Medicine, University of Nottingham, Nottingham, United Kingdom – sequence: 7 givenname: Alan R surname: Smyth fullname: Smyth, Alan R organization: School of Medicine, University of Nottingham, Nottingham, United Kingdom – sequence: 8 givenname: Damian surname: Rivett fullname: Rivett, Damian organization: Department of Natural Sciences, Manchester Metropolitan University, Manchester, United Kingdom – sequence: 9 givenname: Christopher surname: van der Gast fullname: van der Gast, Christopher email: c.vandergast@mmu.ac.uk organization: Department of Life Sciences, Manchester Metropolitan University, Manchester, United Kingdom |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34895838$$D View this record in MEDLINE/PubMed |
BookMark | eNqFks1rFjEQxoNU7If-AV4kRy-7zWQ3-4EgSFFbKHhQQbyEJDurs-6brUm28v73ZnnbS8F6mmF4nifML3PKjvzikbGXIEoQ0JxP5eTGUgoJJUApoH7CTqBrq0IJEEe5V01fQN9Xx-w0xkkIaEXbPWPHVd31qqu6E_b9yieMibyZ-bh6l2jx3PiBp2B8pMRNjIsjk5D_ofST_1gT35ELi6UlGT7sY24iRU6eu30OcnwkG7bRc_Z0NHPEF3f1jH398P7LxWVx_enj1cW768LVSooCHY5Npbpemk6o3rUD1gbM0ICU1lYWa1mrFpUdbSdNDaIBY51zRlroBdjqjL0-5N6E5feal9E7ig7n2Xhc1qhlI_padW0vs_TVnXS1Oxz0TaCdCXt9zyML2oMgbxhjwFE7SmaDknnQrEHojbyedCavN_IaQGfy2QkPnPfhj3neHDyY8dwSBh0doXc4UECX9LDQo-63D9xuJk_OzL9wj3Fa1pB_NWrQUWqhP2_XsB2DhByi1Lcc0P874D-P_wWhc8Ry |
CitedBy_id | crossref_primary_10_1002_ppul_71024 crossref_primary_10_1128_spectrum_01175_23 crossref_primary_10_1039_D4FO00325J crossref_primary_10_1080_17476348_2023_2228194 crossref_primary_10_1016_j_clnesp_2023_04_008 crossref_primary_10_1016_j_jcf_2023_03_008 crossref_primary_10_3390_nu14153160 crossref_primary_10_12938_bmfh_2023_100 crossref_primary_10_1038_s41390_023_02944_0 crossref_primary_10_1186_s40168_024_01780_6 crossref_primary_10_1016_j_jcf_2024_01_005 crossref_primary_10_1186_s12866_023_02788_y crossref_primary_10_3390_nu15173846 crossref_primary_10_1016_j_jcf_2024_05_002 crossref_primary_10_1038_s41390_024_03209_0 crossref_primary_10_1002_ncp_11122 crossref_primary_10_1007_s10620_022_07812_1 |
Cites_doi | 10.1097/MPG.0000000000002864 10.1038/nature12726 10.1371/journal.pone.0208171 10.1038/nrgastro.2015.226 10.1038/s41591-019-0714-x 10.1128/IAI.72.10.6040-6049.2004 10.1371/journal.ppat.1008251 10.1111/nmo.13883 10.1152/ajpgi.00548.2006 10.1016/S0140-6736(16)00576-6 10.1093/cid/cit715 10.1073/pnas.1322269111 10.1186/s40168-020-00810-3 10.1097/MIB.0000000000000972 10.1002/ppul.24766 10.1016/j.jcmgh.2019.07.006 10.1371/journal.pone.0134802 10.3390/jcm8050645 10.1038/nmicrobiol.2017.121 10.1038/nmeth.3869 10.1111/j.1469-0691.2010.03256.x 10.1080/19490976.2018.1534512 10.1371/journal.pone.0198457 10.1186/s13073-020-0710-2 10.1038/s41598-019-55028-7 10.1016/j.jcf.2016.09.004 10.1073/pnas.1714373115 10.1016/j.cmet.2011.02.018 10.1038/srep26985 10.1016/j.jcf.2012.10.003 10.3748/wjg.v22.i40.8929 10.1038/srep22493 10.1038/nmicrobiol.2016.93 10.1186/s12866-017-0968-8 10.1136/gutjnl-2014-308896 10.1093/ecco-jcc/jjv203 10.1128/JB.00274-19 10.1038/ismej.2012.145 10.1371/journal.pone.0116967 10.1101/cshperspect.a009753 10.1371/journal.pone.0174463 10.1038/srep24857 10.1016/j.jcf.2020.04.007 |
ContentType | Journal Article |
Copyright | 2021 Copyright © 2021. Published by Elsevier B.V. |
Copyright_xml | – notice: 2021 – notice: Copyright © 2021. Published by Elsevier B.V. |
DBID | 6I. AAFTH AAYXX CITATION NPM 7X8 |
DOI | 10.1016/j.jcf.2021.11.014 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1873-5010 |
EndPage | 513 |
ExternalDocumentID | 34895838 10_1016_j_jcf_2021_11_014 S156919932102155X 1_s2_0_S156919932102155X |
Genre | Journal Article |
GroupedDBID | --- --K --M .1- .FO .~1 0R~ 1B1 1P~ 1~. 1~5 29K 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABJNI ABMAC ABMZM ABWVN ABXDB ACDAQ ACGFS ACIEU ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADVLN AEBSH AEIPS AEKER AENEX AEUPX AEVXI AEXQZ AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGUBO AGYEJ AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP AXJTR BKOJK BLXMC BNPGV CS3 D-I DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE IXB J1W KOM M41 MO0 N9A O-L O9- OAUVE OI- OK1 OU. OZT P-8 P-9 P2P PC. Q38 ROL RPZ SDF SDG SEL SES SEW SPCBC SSH SSZ T5K UHS Z5R ~G- 0SF 6I. AACTN AAFTH ABVKL AFCTW AFKWA AJOXV AMFUW NCXOZ RIG AAIAV ABLVK ABYKQ AJBFU EFLBG LCYCR AAYXX AGRNS CITATION NPM 7X8 |
ID | FETCH-LOGICAL-c4520-ecef635892a8059c7de4a1ad6122bb3be42457e5bfb82a41061abccca2b1901b3 |
IEDL.DBID | .~1 |
ISSN | 1569-1993 1873-5010 |
IngestDate | Fri Sep 05 06:48:48 EDT 2025 Wed Feb 19 02:25:48 EST 2025 Tue Jul 01 04:15:55 EDT 2025 Thu Apr 24 23:06:14 EDT 2025 Fri Feb 23 02:39:49 EST 2024 Tue Feb 25 20:08:12 EST 2025 Tue Aug 26 16:33:15 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Gut microbiota Intestinal physiology Antibiotics Dysbiosis MRI Gut microbiome |
Language | English |
License | This is an open access article under the CC BY license. Copyright © 2021. Published by Elsevier B.V. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4520-ecef635892a8059c7de4a1ad6122bb3be42457e5bfb82a41061abccca2b1901b3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S156919932102155X |
PMID | 34895838 |
PQID | 2609458792 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_2609458792 pubmed_primary_34895838 crossref_citationtrail_10_1016_j_jcf_2021_11_014 crossref_primary_10_1016_j_jcf_2021_11_014 elsevier_sciencedirect_doi_10_1016_j_jcf_2021_11_014 elsevier_clinicalkeyesjournals_1_s2_0_S156919932102155X elsevier_clinicalkey_doi_10_1016_j_jcf_2021_11_014 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-05-01 |
PublicationDateYYYYMMDD | 2022-05-01 |
PublicationDate_xml | – month: 05 year: 2022 text: 2022-05-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Journal of cystic fibrosis |
PublicationTitleAlternate | J Cyst Fibros |
PublicationYear | 2022 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | Takeshita, Mizuno, Mikami, Sujino, Saigusa, Matsuoka (bib0044) 2016; 22 Kastl, Terry, Wu, Albenberg (bib0033) 2020; 9 Chang, Hao, Offermanns, Medzhitov (bib0013) 2014; 111 Tetard, Mittaine, Bui, Beaufils, Maumus, Fayon (bib0051) 2020; 71 Antosca, Chernikova, Price, Ruoff, Li, Guill (bib0006) 2019; 201 De Freitas, Moreira, Tomio, Moreno, Daltoe, Barbosa (bib0015) 2018; 13 Malagelada, Bendezú, Seguí, Vitrià, Merino, Nieto (bib0019) 2020; 00 Madan, Koestle, Stanton, Davidson, Moulton, Housman, Moore, Guill, Morrison, Sogin, Hampton, Karagas, Palumbo, Foster, Hibberd, O'Toole (bib0030) 2012; 3 Hayden, Eng, Pope, Brittnacher, Vo, Weiss (bib0036) 2020; 26 Smith, Rowbotham, Davies, Gathercole, Collins, Elliott (bib0005) 2020; 7 Flass, Tong, Frank, Wagner, Robertson, Kotter (bib0016) 2015; 10 Al-Momani, Perry, Stewart, Jones, Krishnan, Robertson (bib0031) 2016; 6 Vermeire, Joossens, Verbeke, Wang, Machiels, Sabino (bib0045) 2016; 10 Rainey, Hollen, Small, Genus (bib0039) 2009 Roager, Hansen, Bahl, Frandsen, Carvalho, Gøbel (bib0043) 2016; 1 Enaud, Hooks, Barre, Barnetche, Hubert, Massot (bib0029) 2019; 8 Gorzelak, Gill, Tasnim, Ahmadi-Vand, Jay, Gibson (bib0021) 2015; 10 Li, Wang, Wei, Gao, Zhang, Wang (bib0038) 2016; 22 De Lisle (bib0047) 2007; 293 Nagy, Urbán, Nord (bib0050) 2011; 17 Zaneveld, McMinds, Thurber (bib0028) 2017; 2 Meeker, Mears, Sangwan, Brittnacher, Weiss, Treuting, Tolley, Pope, Hager, Vo, Paik, Frevert, Hayden, Hoffman, Miller, Hajjar (bib0042) 2020; 16 Elborn (bib0041) 2016; 388 Arpaia, Campbell, Fan, Dikiy, van der Veeken, DeRoos (bib0014) 2013; 504 ter Braak, Smilauer (bib0025) 2012 Matamouros, Hayden, Hager, Brittnacher, Lachance, Weiss (bib0049) 2018; 115 Kristensen, Prevaes, Kalkman, Tramper-Stranders, Hasrat, de Winter- de Groot (bib0010) 2020 Duytschaever, Huys, Bekaert, Boulanger, De Boeck, Vandamme (bib0037) 2013; 12 Norkina, Burnett, De Lisle (bib0046) 2004; 72 Burke, Fouhy, Harrison, Rea, Cotter, Sullivan, Stanton, Hill, Shanahan, Plant, Ross (bib0008) 2017; 17 Donohoe, Garge, Zhang, Sun, O'Connell, Bunger, Bultman (bib0012) 2011; 13 Loman, Shrestha, Thompson, Groner, Mejias, Ruoff (bib0007) 2020; 55 Vernocchi, Del Chierico, Russo, Majo, Rossitto, Valerio (bib0011) 2018; 13 Tabori, Arnold, Jaudszus, Mentzel, Renz, Reinsch (bib0003) 2017; 12 Øyvind Hammer, Harper (bib0024) 2001; 4 Dayama, Priya, Niccum, Khoruts, Blekhman (bib0017) 2020; 12 Cuthbertson, Walker, Oliver, Rogers, Rivett, Hampton, Ashare, Elborn, De Soyza, Carroll, Hoffman, Lanyon, Moskowitz, O'Toole, Parkhill, Planet, Teneback, Tunney, Zuckerman, Bruce, van der Gast (bib0026) 2020; 8 Hoffman, Pope, Hayden, Heltshe, Levy, McNamara (bib0035) 2014; 58 Manor, Levy, Pope, Hayden, Brittnacher, Carr (bib0034) 2016; 6 Rogers, Cuthbertson, Hoffman, Wing, Pope, Hooftman, Lilley, Oliver, Carroll, Bruce, van der Gast (bib0022) 2013; 7 Anderson, Miles, Tierney (bib0032) 2017; 16 Wang, Leong, Keating, Kanno, Abell, Mobegi, Choo, Wesselingh, Mason, Burr, Rogers (bib0040) 2019; 10 Hedin, van der Gast, Rogers, Cuthbertson, McCartney, Stagg (bib0027) 2016; 65 Coffey, Nielsen, Wemheuer, Kaakoush, Garg, Needham (bib0018) 2019; 9 Ng, Dellschaft, Hoad, Marciani, Ban, Prayle (bib0020) 2020 Hayee, Watson, Campbell, Simpson, Farrell, Hutchings (bib0004) 2019; 7 Nielsen, Needham, Leach, Day, Jaffe, Thomas (bib0009) 2016; 6 Ooi, Durie (bib0002) 2016; 13 De Lisle, Borowitz (bib0001) 2013; 3 Callahan, McMurdie, Rosen, Han, Johnson, Holmes (bib0023) 2016; 13 Collins (bib0048) 2018; 26 Loman (10.1016/j.jcf.2021.11.014_bib0007) 2020; 55 Meeker (10.1016/j.jcf.2021.11.014_bib0042) 2020; 16 Callahan (10.1016/j.jcf.2021.11.014_bib0023) 2016; 13 Malagelada (10.1016/j.jcf.2021.11.014_bib0019) 2020; 00 Øyvind Hammer (10.1016/j.jcf.2021.11.014_bib0024) 2001; 4 Smith (10.1016/j.jcf.2021.11.014_bib0005) 2020; 7 ter Braak (10.1016/j.jcf.2021.11.014_bib0025) 2012 Roager (10.1016/j.jcf.2021.11.014_bib0043) 2016; 1 Arpaia (10.1016/j.jcf.2021.11.014_bib0014) 2013; 504 Nagy (10.1016/j.jcf.2021.11.014_bib0050) 2011; 17 De Lisle (10.1016/j.jcf.2021.11.014_bib0047) 2007; 293 Burke (10.1016/j.jcf.2021.11.014_bib0008) 2017; 17 Vernocchi (10.1016/j.jcf.2021.11.014_bib0011) 2018; 13 Kastl (10.1016/j.jcf.2021.11.014_bib0033) 2020; 9 Hoffman (10.1016/j.jcf.2021.11.014_bib0035) 2014; 58 Kristensen (10.1016/j.jcf.2021.11.014_bib0010) 2020 Antosca (10.1016/j.jcf.2021.11.014_bib0006) 2019; 201 Tabori (10.1016/j.jcf.2021.11.014_bib0003) 2017; 12 Elborn (10.1016/j.jcf.2021.11.014_bib0041) 2016; 388 Donohoe (10.1016/j.jcf.2021.11.014_bib0012) 2011; 13 Zaneveld (10.1016/j.jcf.2021.11.014_bib0028) 2017; 2 Ooi (10.1016/j.jcf.2021.11.014_bib0002) 2016; 13 Al-Momani (10.1016/j.jcf.2021.11.014_bib0031) 2016; 6 De Freitas (10.1016/j.jcf.2021.11.014_bib0015) 2018; 13 Tetard (10.1016/j.jcf.2021.11.014_bib0051) 2020; 71 Rainey (10.1016/j.jcf.2021.11.014_bib0039) 2009 Madan (10.1016/j.jcf.2021.11.014_bib0030) 2012; 3 Ng (10.1016/j.jcf.2021.11.014_bib0020) 2020 Hedin (10.1016/j.jcf.2021.11.014_bib0027) 2016; 65 Collins (10.1016/j.jcf.2021.11.014_bib0048) 2018; 26 Matamouros (10.1016/j.jcf.2021.11.014_bib0049) 2018; 115 Takeshita (10.1016/j.jcf.2021.11.014_bib0044) 2016; 22 Anderson (10.1016/j.jcf.2021.11.014_bib0032) 2017; 16 Norkina (10.1016/j.jcf.2021.11.014_bib0046) 2004; 72 Gorzelak (10.1016/j.jcf.2021.11.014_bib0021) 2015; 10 Duytschaever (10.1016/j.jcf.2021.11.014_bib0037) 2013; 12 Flass (10.1016/j.jcf.2021.11.014_bib0016) 2015; 10 Rogers (10.1016/j.jcf.2021.11.014_bib0022) 2013; 7 Coffey (10.1016/j.jcf.2021.11.014_bib0018) 2019; 9 Enaud (10.1016/j.jcf.2021.11.014_bib0029) 2019; 8 Nielsen (10.1016/j.jcf.2021.11.014_bib0009) 2016; 6 Dayama (10.1016/j.jcf.2021.11.014_bib0017) 2020; 12 Hayden (10.1016/j.jcf.2021.11.014_bib0036) 2020; 26 Chang (10.1016/j.jcf.2021.11.014_bib0013) 2014; 111 Hayee (10.1016/j.jcf.2021.11.014_bib0004) 2019; 7 Vermeire (10.1016/j.jcf.2021.11.014_bib0045) 2016; 10 Wang (10.1016/j.jcf.2021.11.014_bib0040) 2019; 10 Li (10.1016/j.jcf.2021.11.014_bib0038) 2016; 22 De Lisle (10.1016/j.jcf.2021.11.014_bib0001) 2013; 3 Manor (10.1016/j.jcf.2021.11.014_bib0034) 2016; 6 Cuthbertson (10.1016/j.jcf.2021.11.014_bib0026) 2020; 8 |
References_xml | – volume: 6 start-page: 22493 year: 2016 ident: bib0034 article-title: Metagenomic evidence for taxonomic dysbiosis and functional imbalance in the gastrointestinal tracts of children with cystic fibrosis publication-title: Sci Rep – volume: 504 start-page: 451 year: 2013 end-page: 455 ident: bib0014 article-title: Metabolites produced by commensal bacteria promote peripheral regulatory T cell generation publication-title: Nature – volume: 13 year: 2018 ident: bib0011 article-title: Gut microbiota signatures in cystic fibrosis: Loss of host CFTR function drives the microbiota enterophenotype publication-title: PLoS One – volume: 9 start-page: 18593 year: 2019 ident: bib0018 article-title: Gut Microbiota in Children With Cystic Fibrosis: A Taxonomic and Functional Dysbiosis publication-title: Sci Rep – volume: 8 start-page: 645 year: 2019 ident: bib0029 article-title: Intestinal Inflammation in Children with Cystic Fibrosis Is Associated with Crohn’s-Like Microbiota Disturbances publication-title: J Clin Med – volume: 65 start-page: 944 year: 2016 end-page: 953 ident: bib0027 article-title: Siblings of patients with Crohn’s disease exhibit a biologically relevant dysbiosis in mucosal microbial metacommunities publication-title: Gut – volume: 13 year: 2018 ident: bib0015 article-title: Altered intestinal microbiota composition, antibiotic therapy and intestinal inflammation in children and adolescents with cystic fibrosis publication-title: PLoS One – year: 2020 ident: bib0010 article-title: Development of the gut microbiota in early life: The impact of cystic fibrosis and antibiotic treatment publication-title: J Cyst Fibros – volume: 201 year: 2019 ident: bib0006 article-title: Altered Stool Microbiota of Infants with Cystic Fibrosis Shows a Reduction in Genera Associated with Immune Programming from Birth publication-title: J Bacteriol – volume: 1 start-page: 16093 year: 2016 ident: bib0043 article-title: Colonic transit time is related to bacterial metabolism and mucosal turnover in the gut publication-title: Nat Microbiol – volume: 13 start-page: 175 year: 2016 end-page: 185 ident: bib0002 article-title: Cystic fibrosis from the gastroenterologist’s perspective publication-title: Nat Rev Gastroenterol Hepatol – volume: 10 start-page: 387 year: 2016 end-page: 394 ident: bib0045 article-title: Donor Species Richness Determines Faecal Microbiota Transplantation Success in Inflammatory Bowel Disease publication-title: J Crohn’s Colitis – year: 2020 ident: bib0020 article-title: Postprandial changes in gastrointestinal function and transit in cystic fibrosis assessed by Magnetic Resonance Imaging publication-title: J Cyst Fibros – volume: 58 start-page: 396 year: 2014 end-page: 399 ident: bib0035 article-title: Escherichia coli dysbiosis correlates with gastrointestinal dysfunction in children with cystic fibrosis publication-title: Clin Infect Dis – year: 2012 ident: bib0025 article-title: CANOCO reference manual and user's guide: software for ordination – volume: 13 start-page: 517 year: 2011 end-page: 526 ident: bib0012 article-title: The Microbiome and Butyrate Regulate Energy Metabolism and Autophagy in the Mammalian Colon publication-title: Cell Metab – volume: 9 start-page: 33 year: 2020 end-page: 45 ident: bib0033 article-title: The Structure and Function of the Human Small Intestinal Microbiota: Current Understanding and Future Directions publication-title: Cell Mol Gastroenterol Hepatol – volume: 10 year: 2015 ident: bib0016 article-title: Intestinal lesions are associated with altered intestinal microbiome and are more frequent in children and young adults with cystic fibrosis and cirrhosis publication-title: PLoS One – volume: 7 start-page: 697 year: 2013 end-page: 706 ident: bib0022 article-title: Reducing bias in bacterial community analysis of lower respiratory infections publication-title: ISME J – volume: 6 start-page: 26985 year: 2016 ident: bib0031 article-title: Microbiological profiles of sputum and gastric juice aspirates in Cystic Fibrosis patients publication-title: Sci Rep – year: 2009 ident: bib0039 article-title: Clostridium prazmowski 1880, 23AL – volume: 12 start-page: 12 year: 2020 ident: bib0017 article-title: Interactions between the gut microbiome and host gene regulation in cystic fibrosis publication-title: Genome Med – volume: 17 start-page: 58 year: 2017 ident: bib0008 article-title: The altered gut microbiota in adults with cystic fibrosis publication-title: BMC Microbiol – volume: 16 year: 2020 ident: bib0042 article-title: CFTR dysregulation drives active selection of the gut microbiome publication-title: PLoS Pathog – volume: 72 start-page: 6040 year: 2004 end-page: 6049 ident: bib0046 article-title: Bacterial overgrowth in the cystic fibrosis transmembrane conductance regulator null mouse small intestine publication-title: Infect Immun – volume: 00 start-page: e13883 year: 2020 ident: bib0019 article-title: Motor dysfunction of the gut in cystic fibrosis publication-title: Neurogastroenterol Motil – volume: 7 start-page: 881 year: 2019 end-page: 888 ident: bib0004 article-title: A high prevalence of chronic gastrointestinal symptoms in adults with cystic fibrosis is detected using tools already validated in other GI disorders, United Eur publication-title: Gastroenterol J – volume: 6 start-page: 24857 year: 2016 ident: bib0009 article-title: Disrupted progression of the intestinal microbiota with age in children with cystic fibrosis publication-title: Sci Rep – volume: 8 start-page: 45 year: 2020 ident: bib0026 article-title: Lung function and microbiota diversity in cystic fibrosis publication-title: Microbiome – volume: 10 year: 2015 ident: bib0021 article-title: Methods for improving human gut microbiome data by reducing variability through sample processing and storage of stool publication-title: PLoS One – volume: 16 start-page: 186 year: 2017 end-page: 197 ident: bib0032 article-title: Effect of probiotics on respiratory, gastrointestinal and nutritional outcomes in patients with cystic fibrosis: A systematic review publication-title: J Cyst Fibros – volume: 293 start-page: 104 year: 2007 end-page: 111 ident: bib0047 article-title: Altered transit and bacterial overgrowth in the cystic fibrosis mouse small intestine publication-title: Am J Physiol Gastrointest Liver Physiol – volume: 12 start-page: 206 year: 2013 end-page: 215 ident: bib0037 article-title: Dysbiosis of bifidobacteria and Clostridium cluster XIVa in the cystic fibrosis fecal microbiota publication-title: J Cyst Fibros – volume: 17 start-page: 371 year: 2011 end-page: 379 ident: bib0050 article-title: Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience publication-title: Clin Microbiol Infect – volume: 12 year: 2017 ident: bib0003 article-title: Abdominal symptoms in cystic fibrosis and their relation to genotype, history, clinical and laboratory findings publication-title: PLoS One – volume: 26 start-page: 4 year: 2018 end-page: 6 ident: bib0048 article-title: Nutritional management of cystic fibrosis – an update for the 21st century publication-title: Paediatr Respir Rev – volume: 115 start-page: 1605 year: 2018 end-page: 1610 ident: bib0049 article-title: Adaptation of commensal proliferating Escherichia coli to the intestinal tract of young children with cystic fibrosis publication-title: Proc Natl Acad Sci U S A – volume: 3 year: 2013 ident: bib0001 article-title: The cystic fibrosis intestine publication-title: Cold Spring Harb Perspect Med – volume: 111 start-page: 2247 year: 2014 end-page: 2252 ident: bib0013 article-title: The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition publication-title: Proc Natl Acad Sci U S A – volume: 2 start-page: 17121 year: 2017 ident: bib0028 article-title: Stress and stability: Applying the Anna Karenina principle to animal microbiomes publication-title: Nat Microbiol – volume: 7 year: 2020 ident: bib0005 article-title: How can we relieve gastrointestinal symptoms in people with cystic fibrosis? An international qualitative survey publication-title: BMJ Open Respir Res – volume: 22 start-page: 8929 year: 2016 end-page: 8939 ident: bib0038 article-title: Fecal microbiota in pouchitis and ulcerative colitis publication-title: World J Gastroenterol – volume: 55 start-page: 1661 year: 2020 end-page: 1670 ident: bib0007 article-title: Age and environmental exposures influence the fecal bacteriome of young children with cystic fibrosis publication-title: Pediatr Pulmonol – volume: 3 year: 2012 ident: bib0030 article-title: Serial analysis of the gut and respiratory microbiome publication-title: MBio – volume: 26 start-page: 215 year: 2020 end-page: 221 ident: bib0036 article-title: Fecal dysbiosis in infants with cystic fibrosis is associated with early linear growth failure publication-title: Nat Med – volume: 388 start-page: 2519 year: 2016 end-page: 2531 ident: bib0041 article-title: Cystic fibrosis publication-title: Lancet – volume: 4 start-page: 9 year: 2001 ident: bib0024 article-title: PAST: Paleontological Statistics Software Package for Education and Data Analysis publication-title: Palaeontol Electron – volume: 10 start-page: 367 year: 2019 end-page: 381 ident: bib0040 article-title: Opportunistic bacteria confer the ability to ferment prebiotic starch in the adult cystic fibrosis gut publication-title: Gut Microbes – volume: 22 start-page: 2802 year: 2016 end-page: 2810 ident: bib0044 article-title: A single species of clostridium Subcluster XIVa decreased in ulcerative colitis patients publication-title: Inflamm Bowel Dis – volume: 71 start-page: 778 year: 2020 end-page: 781 ident: bib0051 article-title: Reduced Intestinal Inflammation With Lumacaftor/Ivacaftor in Adolescents With Cystic Fibrosis publication-title: J Pediatr Gastroenterol Nutr – volume: 13 start-page: 4 year: 2016 end-page: 5 ident: bib0023 article-title: DADA2: High resolution sample inference from Illumina amplicon data publication-title: Nat Methods – volume: 71 start-page: 778 year: 2020 ident: 10.1016/j.jcf.2021.11.014_bib0051 article-title: Reduced Intestinal Inflammation With Lumacaftor/Ivacaftor in Adolescents With Cystic Fibrosis publication-title: J Pediatr Gastroenterol Nutr doi: 10.1097/MPG.0000000000002864 – volume: 504 start-page: 451 year: 2013 ident: 10.1016/j.jcf.2021.11.014_bib0014 article-title: Metabolites produced by commensal bacteria promote peripheral regulatory T cell generation publication-title: Nature doi: 10.1038/nature12726 – volume: 13 year: 2018 ident: 10.1016/j.jcf.2021.11.014_bib0011 article-title: Gut microbiota signatures in cystic fibrosis: Loss of host CFTR function drives the microbiota enterophenotype publication-title: PLoS One doi: 10.1371/journal.pone.0208171 – volume: 13 start-page: 175 year: 2016 ident: 10.1016/j.jcf.2021.11.014_bib0002 article-title: Cystic fibrosis from the gastroenterologist’s perspective publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/nrgastro.2015.226 – volume: 26 start-page: 215 year: 2020 ident: 10.1016/j.jcf.2021.11.014_bib0036 article-title: Fecal dysbiosis in infants with cystic fibrosis is associated with early linear growth failure publication-title: Nat Med doi: 10.1038/s41591-019-0714-x – volume: 72 start-page: 6040 year: 2004 ident: 10.1016/j.jcf.2021.11.014_bib0046 article-title: Bacterial overgrowth in the cystic fibrosis transmembrane conductance regulator null mouse small intestine publication-title: Infect Immun doi: 10.1128/IAI.72.10.6040-6049.2004 – volume: 7 start-page: 881 year: 2019 ident: 10.1016/j.jcf.2021.11.014_bib0004 article-title: A high prevalence of chronic gastrointestinal symptoms in adults with cystic fibrosis is detected using tools already validated in other GI disorders, United Eur publication-title: Gastroenterol J – volume: 3 year: 2012 ident: 10.1016/j.jcf.2021.11.014_bib0030 article-title: Serial analysis of the gut and respiratory microbiome publication-title: MBio – volume: 16 year: 2020 ident: 10.1016/j.jcf.2021.11.014_bib0042 article-title: CFTR dysregulation drives active selection of the gut microbiome publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1008251 – volume: 00 start-page: e13883 year: 2020 ident: 10.1016/j.jcf.2021.11.014_bib0019 article-title: Motor dysfunction of the gut in cystic fibrosis publication-title: Neurogastroenterol Motil doi: 10.1111/nmo.13883 – volume: 293 start-page: 104 year: 2007 ident: 10.1016/j.jcf.2021.11.014_bib0047 article-title: Altered transit and bacterial overgrowth in the cystic fibrosis mouse small intestine publication-title: Am J Physiol Gastrointest Liver Physiol doi: 10.1152/ajpgi.00548.2006 – year: 2009 ident: 10.1016/j.jcf.2021.11.014_bib0039 – volume: 388 start-page: 2519 year: 2016 ident: 10.1016/j.jcf.2021.11.014_bib0041 article-title: Cystic fibrosis publication-title: Lancet doi: 10.1016/S0140-6736(16)00576-6 – volume: 58 start-page: 396 year: 2014 ident: 10.1016/j.jcf.2021.11.014_bib0035 article-title: Escherichia coli dysbiosis correlates with gastrointestinal dysfunction in children with cystic fibrosis publication-title: Clin Infect Dis doi: 10.1093/cid/cit715 – volume: 111 start-page: 2247 year: 2014 ident: 10.1016/j.jcf.2021.11.014_bib0013 article-title: The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1322269111 – volume: 8 start-page: 45 year: 2020 ident: 10.1016/j.jcf.2021.11.014_bib0026 article-title: Lung function and microbiota diversity in cystic fibrosis publication-title: Microbiome doi: 10.1186/s40168-020-00810-3 – year: 2012 ident: 10.1016/j.jcf.2021.11.014_bib0025 – volume: 22 start-page: 2802 year: 2016 ident: 10.1016/j.jcf.2021.11.014_bib0044 article-title: A single species of clostridium Subcluster XIVa decreased in ulcerative colitis patients publication-title: Inflamm Bowel Dis doi: 10.1097/MIB.0000000000000972 – volume: 55 start-page: 1661 year: 2020 ident: 10.1016/j.jcf.2021.11.014_bib0007 article-title: Age and environmental exposures influence the fecal bacteriome of young children with cystic fibrosis publication-title: Pediatr Pulmonol doi: 10.1002/ppul.24766 – volume: 9 start-page: 33 year: 2020 ident: 10.1016/j.jcf.2021.11.014_bib0033 article-title: The Structure and Function of the Human Small Intestinal Microbiota: Current Understanding and Future Directions publication-title: Cell Mol Gastroenterol Hepatol doi: 10.1016/j.jcmgh.2019.07.006 – volume: 10 year: 2015 ident: 10.1016/j.jcf.2021.11.014_bib0021 article-title: Methods for improving human gut microbiome data by reducing variability through sample processing and storage of stool publication-title: PLoS One doi: 10.1371/journal.pone.0134802 – volume: 8 start-page: 645 year: 2019 ident: 10.1016/j.jcf.2021.11.014_bib0029 article-title: Intestinal Inflammation in Children with Cystic Fibrosis Is Associated with Crohn’s-Like Microbiota Disturbances publication-title: J Clin Med doi: 10.3390/jcm8050645 – volume: 2 start-page: 17121 year: 2017 ident: 10.1016/j.jcf.2021.11.014_bib0028 article-title: Stress and stability: Applying the Anna Karenina principle to animal microbiomes publication-title: Nat Microbiol doi: 10.1038/nmicrobiol.2017.121 – volume: 13 start-page: 4 year: 2016 ident: 10.1016/j.jcf.2021.11.014_bib0023 article-title: DADA2: High resolution sample inference from Illumina amplicon data publication-title: Nat Methods doi: 10.1038/nmeth.3869 – volume: 17 start-page: 371 year: 2011 ident: 10.1016/j.jcf.2021.11.014_bib0050 article-title: Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience publication-title: Clin Microbiol Infect doi: 10.1111/j.1469-0691.2010.03256.x – volume: 10 start-page: 367 year: 2019 ident: 10.1016/j.jcf.2021.11.014_bib0040 article-title: Opportunistic bacteria confer the ability to ferment prebiotic starch in the adult cystic fibrosis gut publication-title: Gut Microbes doi: 10.1080/19490976.2018.1534512 – volume: 13 year: 2018 ident: 10.1016/j.jcf.2021.11.014_bib0015 article-title: Altered intestinal microbiota composition, antibiotic therapy and intestinal inflammation in children and adolescents with cystic fibrosis publication-title: PLoS One doi: 10.1371/journal.pone.0198457 – volume: 12 start-page: 12 year: 2020 ident: 10.1016/j.jcf.2021.11.014_bib0017 article-title: Interactions between the gut microbiome and host gene regulation in cystic fibrosis publication-title: Genome Med doi: 10.1186/s13073-020-0710-2 – volume: 9 start-page: 18593 year: 2019 ident: 10.1016/j.jcf.2021.11.014_bib0018 article-title: Gut Microbiota in Children With Cystic Fibrosis: A Taxonomic and Functional Dysbiosis publication-title: Sci Rep doi: 10.1038/s41598-019-55028-7 – volume: 16 start-page: 186 year: 2017 ident: 10.1016/j.jcf.2021.11.014_bib0032 article-title: Effect of probiotics on respiratory, gastrointestinal and nutritional outcomes in patients with cystic fibrosis: A systematic review publication-title: J Cyst Fibros doi: 10.1016/j.jcf.2016.09.004 – volume: 26 start-page: 4 year: 2018 ident: 10.1016/j.jcf.2021.11.014_bib0048 article-title: Nutritional management of cystic fibrosis – an update for the 21st century publication-title: Paediatr Respir Rev – volume: 115 start-page: 1605 year: 2018 ident: 10.1016/j.jcf.2021.11.014_bib0049 article-title: Adaptation of commensal proliferating Escherichia coli to the intestinal tract of young children with cystic fibrosis publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1714373115 – volume: 13 start-page: 517 year: 2011 ident: 10.1016/j.jcf.2021.11.014_bib0012 article-title: The Microbiome and Butyrate Regulate Energy Metabolism and Autophagy in the Mammalian Colon publication-title: Cell Metab doi: 10.1016/j.cmet.2011.02.018 – volume: 6 start-page: 26985 year: 2016 ident: 10.1016/j.jcf.2021.11.014_bib0031 article-title: Microbiological profiles of sputum and gastric juice aspirates in Cystic Fibrosis patients publication-title: Sci Rep doi: 10.1038/srep26985 – year: 2020 ident: 10.1016/j.jcf.2021.11.014_bib0020 article-title: Postprandial changes in gastrointestinal function and transit in cystic fibrosis assessed by Magnetic Resonance Imaging publication-title: J Cyst Fibros – volume: 12 start-page: 206 year: 2013 ident: 10.1016/j.jcf.2021.11.014_bib0037 article-title: Dysbiosis of bifidobacteria and Clostridium cluster XIVa in the cystic fibrosis fecal microbiota publication-title: J Cyst Fibros doi: 10.1016/j.jcf.2012.10.003 – volume: 22 start-page: 8929 year: 2016 ident: 10.1016/j.jcf.2021.11.014_bib0038 article-title: Fecal microbiota in pouchitis and ulcerative colitis publication-title: World J Gastroenterol doi: 10.3748/wjg.v22.i40.8929 – volume: 6 start-page: 22493 year: 2016 ident: 10.1016/j.jcf.2021.11.014_bib0034 article-title: Metagenomic evidence for taxonomic dysbiosis and functional imbalance in the gastrointestinal tracts of children with cystic fibrosis publication-title: Sci Rep doi: 10.1038/srep22493 – volume: 1 start-page: 16093 year: 2016 ident: 10.1016/j.jcf.2021.11.014_bib0043 article-title: Colonic transit time is related to bacterial metabolism and mucosal turnover in the gut publication-title: Nat Microbiol doi: 10.1038/nmicrobiol.2016.93 – volume: 17 start-page: 58 year: 2017 ident: 10.1016/j.jcf.2021.11.014_bib0008 article-title: The altered gut microbiota in adults with cystic fibrosis publication-title: BMC Microbiol doi: 10.1186/s12866-017-0968-8 – volume: 65 start-page: 944 year: 2016 ident: 10.1016/j.jcf.2021.11.014_bib0027 article-title: Siblings of patients with Crohn’s disease exhibit a biologically relevant dysbiosis in mucosal microbial metacommunities publication-title: Gut doi: 10.1136/gutjnl-2014-308896 – volume: 10 start-page: 387 year: 2016 ident: 10.1016/j.jcf.2021.11.014_bib0045 article-title: Donor Species Richness Determines Faecal Microbiota Transplantation Success in Inflammatory Bowel Disease publication-title: J Crohn’s Colitis doi: 10.1093/ecco-jcc/jjv203 – volume: 7 year: 2020 ident: 10.1016/j.jcf.2021.11.014_bib0005 article-title: How can we relieve gastrointestinal symptoms in people with cystic fibrosis? An international qualitative survey publication-title: BMJ Open Respir Res – volume: 201 year: 2019 ident: 10.1016/j.jcf.2021.11.014_bib0006 article-title: Altered Stool Microbiota of Infants with Cystic Fibrosis Shows a Reduction in Genera Associated with Immune Programming from Birth publication-title: J Bacteriol doi: 10.1128/JB.00274-19 – volume: 7 start-page: 697 year: 2013 ident: 10.1016/j.jcf.2021.11.014_bib0022 article-title: Reducing bias in bacterial community analysis of lower respiratory infections publication-title: ISME J doi: 10.1038/ismej.2012.145 – volume: 10 year: 2015 ident: 10.1016/j.jcf.2021.11.014_bib0016 article-title: Intestinal lesions are associated with altered intestinal microbiome and are more frequent in children and young adults with cystic fibrosis and cirrhosis publication-title: PLoS One doi: 10.1371/journal.pone.0116967 – volume: 3 year: 2013 ident: 10.1016/j.jcf.2021.11.014_bib0001 article-title: The cystic fibrosis intestine publication-title: Cold Spring Harb Perspect Med doi: 10.1101/cshperspect.a009753 – volume: 4 start-page: 9 year: 2001 ident: 10.1016/j.jcf.2021.11.014_bib0024 article-title: PAST: Paleontological Statistics Software Package for Education and Data Analysis publication-title: Palaeontol Electron – volume: 12 year: 2017 ident: 10.1016/j.jcf.2021.11.014_bib0003 article-title: Abdominal symptoms in cystic fibrosis and their relation to genotype, history, clinical and laboratory findings publication-title: PLoS One doi: 10.1371/journal.pone.0174463 – volume: 6 start-page: 24857 year: 2016 ident: 10.1016/j.jcf.2021.11.014_bib0009 article-title: Disrupted progression of the intestinal microbiota with age in children with cystic fibrosis publication-title: Sci Rep doi: 10.1038/srep24857 – year: 2020 ident: 10.1016/j.jcf.2021.11.014_bib0010 article-title: Development of the gut microbiota in early life: The impact of cystic fibrosis and antibiotic treatment publication-title: J Cyst Fibros doi: 10.1016/j.jcf.2020.04.007 |
SSID | ssj0017078 |
Score | 2.425142 |
Snippet | •Faecal microbiota significantly differs between pwCF and healthy controls.•Known SCFA producers contributed to microbiota dissimilarity between... Highlights•Faecal microbiota significantly differs between pwCF and healthy controls. •Known SCFA producers contributed to microbiota dissimilarity between... Most people with cystic fibrosis (pwCF) suffer from gastrointestinal symptoms and are at risk of gut complications. Gut microbiota dysbiosis is apparent within... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 506 |
SubjectTerms | Antibiotics Dysbiosis Gut microbiome Gut microbiota Intestinal physiology MRI Pulmonary/Respiratory |
Title | Intestinal function and transit associate with gut microbiota dysbiosis in cystic fibrosis |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S156919932102155X https://www.clinicalkey.es/playcontent/1-s2.0-S156919932102155X https://dx.doi.org/10.1016/j.jcf.2021.11.014 https://www.ncbi.nlm.nih.gov/pubmed/34895838 https://www.proquest.com/docview/2609458792 |
Volume | 21 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB5CCiWX0kfSbh9BgZ4Km7VleS0d09CwaUgubWDJRUjyuDgkToi9h1z62ztjywulTQq92cJC9kjz-KyZTwAfvVEmQ2mmSWlyAigl6VxpFKGUBCvUJk_6Cu_Ts_niXH1d5ssNOBxrYTitMtr-wab31jq2zKI0Z7d1PftGyMNw-hmDFvKKS65gVwXz5-__XKd5pMxm03Omzg0nVWTjzmaf43UZmMVTpvtM5Jmqh3zTQ7Fn74OOnsOzGDyKg-H9XsAGNi_h6WncHn8FF_x_j3SWH2KHxUIXrilFxx6p7oSLk4GC_7-KH6tOXNcDFVPnRHnf0kVbt6JuRLhnBmdREZzmpm04P_ry_XAxjYcnTIPKCRJiwIqCCW2k0xRChaJE5VJXUkQjvc888pZngbmvvJZOMTJ0PtB8Ss8xgs92YLO5afANiJBQOybeVUjgyUuda3QVaf88FBTuphNIRrHZEJnF-YCLKzumkF1akrRlSRPisCTpCXxad7kdaDUee1iOc2HHelGycJaM_mOdir91wjbqaGtT20qb2D_W0QTUuudvS_FfA-6Ny8SSivK-i2vwZtVagoxG5bowcgKvh_Wz_uhMkT7oTL_9v0HfwZbkeow-A_M9bHZ3K_xAUVLnd3s12IUnB8cnizO6O15-_gX66hFF |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIgEXVN5LeRiJE9J2E8fZ2MeqarVAtxdaacXFsp1JlQrSimQPvfDbmUmclRC0SNwiKyMn43l99swY4L03ymQozTQpTU4ApSSdK40ilJJghdrkSV_hvTyZL87Up1W-2oKDsRaG0yqj7R9sem-t48gscnN2VdezL4Q8DKefMWghr7i6A3dVnhUs2ns_N3keKbez6Zumzg1nVWTj0Waf5HURuI2nTPe4k2eqbnJONwWfvRM62oGHMXoU-8MHPoItbB7DvWU8H38CX3mDj5SWX2KPxVwXrilFxy6p7oSLq4GCN2DF-boT3-uhF1PnRHnd0kNbt6JuRLjmFs6iIjzNQ0_h7Ojw9GAxjbcnTIPKCRNiwIqiCW2k0xRDhaJE5VJXUkgjvc888plngbmvvJZOMTR0PtCCSs9Bgs-ewXZz2eALECGhcUy8q5DQk5c61-gqUv95KCjeTSeQjGyzIbYW5xsuvtkxh-zCEqctc5oghyVOT-DDhuRq6Ktx28tyXAs7FoySibNk9W8jKv5GhG1U0tamtpU2sX8I0gTUhvI3WfzXhO9GMbGko3zw4hq8XLeWMKNRuS6MnMDzQX42P50pUgid6Zf_N-lbuL84XR7b448nn3fhgeTijD4d8xVsdz_W-JpCps6_6VXiF8TWEdc |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Intestinal+function+and+transit+associate+with+gut+microbiota+dysbiosis+in+cystic+fibrosis&rft.jtitle=Journal+of+cystic+fibrosis&rft.au=Marsh%2C+Ryan&rft.au=Gavillet%2C+Helen&rft.au=Hanson%2C+Liam&rft.au=Ng%2C+Christabella&rft.date=2022-05-01&rft.eissn=1873-5010&rft.volume=21&rft.issue=3&rft.spage=506&rft_id=info:doi/10.1016%2Fj.jcf.2021.11.014&rft_id=info%3Apmid%2F34895838&rft.externalDocID=34895838 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F15691993%2FS1569199322X00040%2Fcov150h.gif |